98 related articles for article (PubMed ID: 3008817)
21. Mercaptan and dicarboxylate inhibitors of hamster dihydroorotase.
Christopherson RI; Schmalzl KJ; Szabados E; Goodridge RJ; Harsanyi MC; Sant ME; Algar EM; Anderson JE; Armstrong A; Sharma SC
Biochemistry; 1989 Jan; 28(2):463-70. PubMed ID: 2565732
[TBL] [Abstract][Full Text] [Related]
22. N alpha-(diphenoxyphosphoryl)-L-alanyl-L-proline, N alpha-[bis (4-nitrophenoxy)phosphoryl]-L-alanyl-L-proline, and N alpha-[ (2-phenylethyl)phenoxyphosphoryl]-L-alanyl-L-proline: releasers of potent inhibitors of angiotensin converting enzyme at physiological pH and temperature.
Galardy RE; Grobelny D
J Med Chem; 1985 Oct; 28(10):1422-7. PubMed ID: 2995664
[TBL] [Abstract][Full Text] [Related]
23. Postproline cleaving enzyme: kinetic studies of size and stereospecificity of its active site.
Walter R; Yoshimoto T
Biochemistry; 1978 Oct; 17(20):4139-44. PubMed ID: 708698
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of angiotensin-converting enzyme by dipeptide analogs.
Schwab A; Macerata R; Rogers W; Barton J; Skiles J; Khandwala A
Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):339-45. PubMed ID: 6095384
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline.
Almquist RG; Chao WR; Jennings-White C
J Med Chem; 1985 Aug; 28(8):1067-71. PubMed ID: 2991518
[TBL] [Abstract][Full Text] [Related]
26. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of angiotensin converting enzyme by L-alanyl-4 or 5-substituted-L-prolines and their N alpha-phosphoryl-derivatives.
Alexandrou EN; Liakopoulou-Kyriakides M
Biochem Int; 1990; 21(2):271-8. PubMed ID: 2403366
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo.
Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL
Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues.
Thaisrivongs S; Pals DT; Kati WM; Turner SR; Thomasco LM; Watt W
J Med Chem; 1986 Oct; 29(10):2080-7. PubMed ID: 3531517
[TBL] [Abstract][Full Text] [Related]
30. Substrate-related potent inhibitors of brain metalloendopeptidase.
Orlowski M; Michaud C; Molineaux CJ
Biochemistry; 1988 Jan; 27(2):597-602. PubMed ID: 3162384
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of angiotensin converting enzyme with N alpha-phosphoryl-L-alanyl-L-proline and N alpha-L-valyl-L-tryptophan.
Galardy RE
Biochem Biophys Res Commun; 1980 Nov; 97(1):94-9. PubMed ID: 6257245
[No Abstract] [Full Text] [Related]
33. Inhibition of arginine aminopeptidase by bestatin and arphamenine analogues. Evidence for a new mode of binding to aminopeptidases.
Harbeson SL; Rich DH
Biochemistry; 1988 Sep; 27(19):7301-10. PubMed ID: 3207677
[TBL] [Abstract][Full Text] [Related]
34. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.
Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236
[TBL] [Abstract][Full Text] [Related]
36. Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitors.
Natarajan S; Gordon EM; Sabo EF; Godfrey JD; Weller HN; Pluscec J; Rom MB; Cushman DW
Biochem Biophys Res Commun; 1984 Oct; 124(1):141-7. PubMed ID: 6093782
[TBL] [Abstract][Full Text] [Related]
37. Post-proline cleaving enzyme from lamb brain.
Yoshimoto T; Simmons WH; Kita T; Tsuru D
J Biochem; 1981 Aug; 90(2):325-34. PubMed ID: 7028730
[TBL] [Abstract][Full Text] [Related]
38. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors.
Bonneau PR; Grand-Maître C; Greenwood DJ; Lagacé L; LaPlante SR; Massariol MJ; Ogilvie WW; O'Meara JA; Kawai SH
Biochemistry; 1997 Oct; 36(41):12644-52. PubMed ID: 9376371
[TBL] [Abstract][Full Text] [Related]
39. Substrate binding properties of converting enzyme using a series of p-nitrophenylalanyl derivatives of angiotensin I.
Massey TH; Fessler DC
Biochemistry; 1976 Nov; 15(22):4906-12. PubMed ID: 186098
[TBL] [Abstract][Full Text] [Related]
40. 13C NMR study of the stereospecificity of the thiohemiacetals formed on inhibition of papain by specific enantiomeric aldehydes.
Mackenzie NE; Grant SK; Scott AI; Malthouse JP
Biochemistry; 1986 Apr; 25(8):2293-8. PubMed ID: 3707946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
